|Post doc position in the USA|
A Postdoc position is proposed for 2 to 3 years, located in US with a collaborative work between MedImmune Company through R Herbst (US) and Inserm through D Damotte (France).
The objective of the project is to analyse the modulation of lung anti-tumor immune responses by COPD-associated chronic inflammation.
The post doc will develop and implement mouse models of COPD and lung cancer. Importantly, these models will be combined to investigate the direct impact of COPD and underlying inflammation on lung tumor development. These models will also be used to determine if/how lung tumour changes the COPD-associated inflammatory environment and vice versa. The project is part of a global study including a human part which will be conducted in Paris (France) in collaboration with another postdoc already recruited.
Applicants should have interest in immunity and cancer, and if possible aware of mouse manipulation.